QuidelOrtho Corporation - Common Stock - balanço patrimonial (NASDAQ:QDEL)

Financials

Total de ativos 8.86 B8.56 B6.42 B5.77 B Total de passivos 3.92 B3.56 B3.44 B3.85 B Capital total -67.6 M-30 M-36.2 M-15.4 M Total de passivos e patrimônio líquido 8.86 B8.56 B6.42 B5.77 B Dívida total 208.7 M140.2 M—— Dívida líquida -136.3 M-27.1 M——

QuidelOrtho Corporation - Common Stock

QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide. On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs.

QDEL

Financials

QuidelOrtho Corporation - Common Stock

Notícias

QuidelOrtho: A Growing, Stable Business With A Significant Mispricing (NASDAQ:QDEL)

McIntyre Partnerships Q1 2026 Partners Letter

Jefferies rebaixa Quidel por preocupações com visibilidade de lucros

QDEL Stock Down as Q1 Earnings Miss Estimates, Revenues Down Y/Y

QuidelOrtho Corporation (QDEL) Q1 2026 Earnings Call Transcript

Resultados do 1º tri 2026 da QuidelOrtho: receita cai 13% com fraqueza respiratória

QuidelOrtho (QDEL) Reports Q1 Loss, Tops Revenue Estimates

Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for

Earnings Preview: QuidelOrtho (QDEL) Q1 Earnings Expected to Decline

QuidelOrtho Looks Mispriced If 2026's FCF Turnaround Materializes (NASDAQ:QDEL)

Stocks Settle Higher on Tech Earnings and Ceasefire Optimism

Stocks Edge Higher as Chipmakers Rebound